Truvestments Capital LLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Truvestments Capital LLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$639600.0%0.00%
Q3 2022$0600.0%0.00%
Q2 2022$0600.0%0.00%
Q4 2021$0
-100.0%
600.0%0.00%
-100.0%
Q3 2021$1,000600.0%0.00%
Q2 2021$0600.0%0.00%
Q1 2021$0
-100.0%
60
-71.4%
0.00%
-100.0%
Q4 2020$1,0002100.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Interchange Capital Partners, LLC 11,420$90,0000.14%
GSA CAPITAL PARTNERS LLP 47,097$373,0000.04%
GOODWIN DANIEL L 10,000$80,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 99,166$784,0000.01%
EMFO, LLC 1,666$13,0000.01%
PINNACLE ASSOCIATES LTD 34,333$272,0000.01%
BLAIR WILLIAM & CO/IL 51,466$407,0000.00%
Tarbox Family Office, Inc. 332$3,0000.00%
Hartford Financial Management Inc. 598$5,0000.00%
Tower Research Capital LLC (TRC) 3,808$30,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders